Concepts (77)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 11 | 2023 | 1113 | 1.220 |
Why?
|
| Brachytherapy | 7 | 2007 | 40 | 1.090 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 2 | 2015 | 25 | 0.570 |
Why?
|
| Carcinoma, Ductal, Breast | 3 | 2006 | 43 | 0.350 |
Why?
|
| Radiation Injuries | 2 | 2006 | 51 | 0.320 |
Why?
|
| Radiotherapy, Conformal | 1 | 2006 | 18 | 0.270 |
Why?
|
| Catheterization | 1 | 2006 | 104 | 0.260 |
Why?
|
| Asphyxia Neonatorum | 1 | 2003 | 1 | 0.230 |
Why?
|
| Hypoxia, Brain | 1 | 2003 | 8 | 0.230 |
Why?
|
| Exercise | 1 | 2010 | 882 | 0.220 |
Why?
|
| Radiotherapy, Adjuvant | 2 | 2015 | 64 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2015 | 1761 | 0.190 |
Why?
|
| Mastectomy, Segmental | 4 | 2015 | 43 | 0.180 |
Why?
|
| Radiotherapy Dosage | 3 | 2015 | 69 | 0.160 |
Why?
|
| Female | 12 | 2023 | 29032 | 0.140 |
Why?
|
| Neoplasm Invasiveness | 2 | 2015 | 227 | 0.140 |
Why?
|
| Tamoxifen | 1 | 2015 | 34 | 0.130 |
Why?
|
| Carcinoma, Lobular | 1 | 2015 | 20 | 0.130 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2015 | 29 | 0.130 |
Why?
|
| Sentinel Lymph Node Biopsy | 1 | 2015 | 40 | 0.130 |
Why?
|
| Mastectomy | 1 | 2015 | 58 | 0.130 |
Why?
|
| Mammography | 1 | 2015 | 270 | 0.110 |
Why?
|
| Humans | 12 | 2023 | 55585 | 0.100 |
Why?
|
| Body Composition | 1 | 2010 | 172 | 0.080 |
Why?
|
| Adult | 5 | 2010 | 14659 | 0.080 |
Why?
|
| Middle Aged | 6 | 2023 | 14986 | 0.080 |
Why?
|
| Life Style | 1 | 2010 | 334 | 0.080 |
Why?
|
| High Mobility Group Proteins | 1 | 2007 | 19 | 0.080 |
Why?
|
| Motor Activity | 1 | 2010 | 331 | 0.070 |
Why?
|
| Statistics, Nonparametric | 2 | 2006 | 194 | 0.070 |
Why?
|
| Seroma | 1 | 2006 | 7 | 0.070 |
Why?
|
| Radiation | 1 | 2006 | 5 | 0.070 |
Why?
|
| Particle Accelerators | 1 | 2006 | 6 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2007 | 509 | 0.070 |
Why?
|
| Aged | 5 | 2007 | 12323 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2007 | 297 | 0.070 |
Why?
|
| Repressor Proteins | 1 | 2007 | 333 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2007 | 472 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2005 | 449 | 0.060 |
Why?
|
| Basal Ganglia | 1 | 2003 | 29 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2005 | 887 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 400 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 850 | 0.050 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2023 | 89 | 0.050 |
Why?
|
| Neoadjuvant Therapy | 1 | 2023 | 74 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2006 | 4702 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2023 | 298 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 902 | 0.050 |
Why?
|
| Time Factors | 1 | 2007 | 3367 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2023 | 5483 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2003 | 1283 | 0.040 |
Why?
|
| Radiodermatitis | 2 | 2007 | 9 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2003 | 2864 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2007 | 2076 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2007 | 4556 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2007 | 94 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2007 | 158 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2007 | 194 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2007 | 567 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2006 | 29 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2007 | 503 | 0.020 |
Why?
|
| Fat Necrosis | 1 | 2005 | 2 | 0.020 |
Why?
|
| Iridium Radioisotopes | 1 | 2005 | 3 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2005 | 29 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2005 | 93 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2006 | 478 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 329 | 0.020 |
Why?
|
| Recurrence | 1 | 2006 | 528 | 0.020 |
Why?
|
| Radiography | 1 | 2006 | 476 | 0.020 |
Why?
|
| Fibrosis | 1 | 2004 | 111 | 0.010 |
Why?
|
| Male | 1 | 2003 | 25496 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2005 | 294 | 0.010 |
Why?
|
| Skin | 1 | 2004 | 346 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2004 | 808 | 0.010 |
Why?
|
| Mutation | 1 | 2007 | 2325 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 9904 | 0.010 |
Why?
|
| Animals | 1 | 2007 | 18931 | 0.010 |
Why?
|